Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| TransMedics Group, Inc.TMDX · Entity 4261 | Director · President & CEO | July 10, 2026 | July 15, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
TransMedics Group, Inc.
Report date July 10, 2026 · Filed July 15, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 171,093 |
Reported balance
After 2026-07-10 transaction · row 1
1 source rowRow 1 · 2026-07-10 · Grant · Acquired 49,669 · Balance 171,093 F1: Consists of 49,669 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $71.23 · Expires 2036-07-10 | Direct | 112,984 |
Reported balance
After 2026-07-10 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-07-10 · Grant · Acquired 112,984 · Balance 112,984 F3: The option vests at a rate of 2.0833% of the total number of shares subject to the option each month following April 10, 2026 until the option is fully vested on April 10, 2030, subject to continued service. |
| Common StockSEC Table I · non-derivative | IndirectBy the Waleed H. Hassanein Revocable Trust | 345,009 |
Reported balance
Holding disclosure · report date 2026-07-10 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 345,009 F2: Reflects a prior transfer of 150,000 shares of the Issuer's common stock from the Waleed H. Hassanein Revocable Trust to the Hassanein 2026 Qualified Annuity Trust. The transfer constituted only a change in the form of beneficial ownership and was exempt under Rule 16a-13 of the Securities Exchange Act of 1934, as amended. |
| Common StockSEC Table I · non-derivative | IndirectBy the Hassanein 2026 Qualified Annuity Trust | 150,000 |
Reported balance
Holding disclosure · report date 2026-07-10 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 150,000 F2: Reflects a prior transfer of 150,000 shares of the Issuer's common stock from the Waleed H. Hassanein Revocable Trust to the Hassanein 2026 Qualified Annuity Trust. The transfer constituted only a change in the form of beneficial ownership and was exempt under Rule 16a-13 of the Securities Exchange Act of 1934, as amended. |
Filing footnotes · ownership attribution and instrument terms
F1: Consists of 49,669 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.
F2: Reflects a prior transfer of 150,000 shares of the Issuer's common stock from the Waleed H. Hassanein Revocable Trust to the Hassanein 2026 Qualified Annuity Trust. The transfer constituted only a change in the form of beneficial ownership and was exempt under Rule 16a-13 of the Securities Exchange Act of 1934, as amended.
F3: The option vests at a rate of 2.0833% of the total number of shares subject to the option each month following April 10, 2026 until the option is fully vested on April 10, 2030, subject to continued service.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 03, 2023 Filed Apr 4, 2023 21:14 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 3,359 | $74.34 | $249,708.06 |
DisclosureSEC source: 0000899243-23-010442 · doc4.xml · nonDerivative · entry 1 Hassanein Waleed H · CIK 0001430466 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 570,832 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on December 14, 2022. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $73.60 to $74.59, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| March 10, 2023 Filed Mar 14, 2023 21:01 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 193,074 | $0.00 Strike: $2.21 | $0.00 |
DisclosureSEC source: 0000950170-23-007901 · ownership.xml · derivative · entry 2 Hassanein Waleed H · CIK 0001430466 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1 Underlying: Common Stock · 193,074 shares Expires 2027-06-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the reporting person's cash exercise of a stock option. F3 · derivative.exercise_date: The option is fully vested. Read SEC document |
| March 10, 2023 Filed Mar 14, 2023 21:01 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 193,074 | $2.21 | $426,693.54 |
DisclosureSEC source: 0000950170-23-007901 · ownership.xml · nonDerivative · entry 1 Hassanein Waleed H · CIK 0001430466 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 574,191 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the reporting person's cash exercise of a stock option. F2 · balance_after: Includes 37,332 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| March 01, 2023 Filed Mar 2, 2023 22:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 4,900 | $81.01 | $396,949.00 |
DisclosureSEC source: 0000899243-23-006759 · doc4.xml · nonDerivative · entry 2 Hassanein Waleed H · CIK 0001430466 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 381,117 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $80.53 to $81.51, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F4 · balance_after: Includes 37,332 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| March 01, 2023 Filed Mar 2, 2023 22:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 2,600 | $80.17 | $208,442.00 |
DisclosureSEC source: 0000899243-23-006759 · doc4.xml · nonDerivative · entry 1 Hassanein Waleed H · CIK 0001430466 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 386,017 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $79.47 to $80.46, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| February 23, 2023 Filed Feb 28, 2023 01:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 20,000 | $75.15 | $1,503,000.00 |
DisclosureSEC source: 0000899243-23-006282 · doc4.xml · nonDerivative · entry 5 Hassanein Waleed H · CIK 0001430466 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 388,617 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F6 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $75.00 to $75.50, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F7 · balance_after: Includes 37,332 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| February 23, 2023 Filed Feb 28, 2023 01:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 3,243 | $74.52 | $241,668.36 |
DisclosureSEC source: 0000899243-23-006282 · doc4.xml · nonDerivative · entry 4 Hassanein Waleed H · CIK 0001430466 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 408,617 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F5 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $74.00 to $74.90, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| February 23, 2023 Filed Feb 28, 2023 01:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 3,577 | $73.43 | $262,659.11 |
DisclosureSEC source: 0000899243-23-006282 · doc4.xml · nonDerivative · entry 3 Hassanein Waleed H · CIK 0001430466 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 411,860 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $73.10 to $73.93, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| February 23, 2023 Filed Feb 28, 2023 01:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 4,807 | $71.32 | $342,835.24 |
DisclosureSEC source: 0000899243-23-006282 · doc4.xml · nonDerivative · entry 2 Hassanein Waleed H · CIK 0001430466 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 415,437 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $71.00 to $71.63, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| February 23, 2023 Filed Feb 28, 2023 01:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 6,200 | $70.31 | $435,922.00 |
DisclosureSEC source: 0000899243-23-006282 · doc4.xml · nonDerivative · entry 1 Hassanein Waleed H · CIK 0001430466 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 420,244 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $70.00 to $70.85, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| February 20, 2023 Filed Feb 23, 2023 01:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | GrantStock Option (Right to Buy) · Derivative | 57,165 | $0.00 Strike: $66.10 | $0.00 |
DisclosureSEC source: 0000899243-23-005895 · doc4.xml · derivative · entry 2 Hassanein Waleed H · CIK 0001430466 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,165 Underlying: Common Stock · 57,165 shares Expires 2033-02-20 F2 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares subject to the option each month following February 20, 2023 until the option is fully vested on February 20, 2027, subject to continued service. Read SEC document |
| February 20, 2023 Filed Feb 23, 2023 01:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | GrantCommon Stock | 37,332 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-005895 · doc4.xml · nonDerivative · entry 1 Hassanein Waleed H · CIK 0001430466 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 426,444 F1 · shares: Includes 37,332 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 22:06 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 2,173 | $70.08 | $152,283.84 |
DisclosureSEC source: 0000899243-23-005252 · doc4.xml · nonDerivative · entry 1 Hassanein Waleed H · CIK 0001430466 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 389,112 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $70.00 to $70.25, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 22:07 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 7,500 | $64.21 | $481,575.00 |
DisclosureSEC source: 0000899243-23-003884 · doc4.xml · nonDerivative · entry 1 Hassanein Waleed H · CIK 0001430466 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 391,285 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $64.00 to $64.60, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 23, 2023 Filed Jan 25, 2023 22:40 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 900 | $66.12 | $59,508.00 |
DisclosureSEC source: 0000899243-23-002672 · doc4.xml · nonDerivative · entry 2 Hassanein Waleed H · CIK 0001430466 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 398,785 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| January 23, 2023 Filed Jan 25, 2023 22:40 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 11,462 | $65.36 | $749,156.32 |
DisclosureSEC source: 0000899243-23-002672 · doc4.xml · nonDerivative · entry 1 Hassanein Waleed H · CIK 0001430466 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 399,685 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $65.00 to $65.99, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 20, 2023 Filed Jan 20, 2023 23:12 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 6,332 | $65.19 | $412,783.08 |
DisclosureSEC source: 0000899243-23-002273 · doc4.xml · nonDerivative · entry 2 Hassanein Waleed H · CIK 0001430466 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 411,147 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $65.00 to $65.62, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 18, 2023 Filed Jan 20, 2023 23:12 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 1,306 | $65.09 | $85,007.54 |
DisclosureSEC source: 0000899243-23-002273 · doc4.xml · nonDerivative · entry 1 Hassanein Waleed H · CIK 0001430466 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 417,479 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $65.00 to $65.30, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 17, 2023 Filed Jan 18, 2023 23:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 7,500 | $64.14 | $481,050.00 |
DisclosureSEC source: 0000899243-23-002076 · doc4.xml · nonDerivative · entry 1 Hassanein Waleed H · CIK 0001430466 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 418,785 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $64.00 to $64.55, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| November 15, 2022 Filed Nov 16, 2022 22:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 14,483 | $60.13 | $870,862.79 |
DisclosureSEC source: 0000899243-22-036015 · doc4.xml · nonDerivative · entry 1 Hassanein Waleed H · CIK 0001430466 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 426,285 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $60.00 to $60.76, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| November 11, 2022 Filed Nov 15, 2022 00:14 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 2,748 | $60.03 | $164,962.44 |
DisclosureSEC source: 0000899243-22-035753 · doc4.xml · nonDerivative · entry 1 Hassanein Waleed H · CIK 0001430466 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 440,768 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $60.00 to $60.21, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| November 07, 2022 Filed Nov 9, 2022 22:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 2,769 | $60.07 | $166,333.83 |
DisclosureSEC source: 0000899243-22-035448 · doc4.xml · nonDerivative · entry 1 Hassanein Waleed H · CIK 0001430466 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 443,516 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $60.00 to $60.32, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| September 08, 2022 Filed Sep 9, 2022 21:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 17,723 | $55.37 | $981,322.51 |
DisclosureSEC source: 0000899243-22-030737 · doc4.xml · nonDerivative · entry 2 Hassanein Waleed H · CIK 0001430466 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 446,285 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $55.00 to $55.90, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| September 07, 2022 Filed Sep 9, 2022 21:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 2,277 | $55.00 | $125,235.00 |
DisclosureSEC source: 0000899243-22-030737 · doc4.xml · nonDerivative · entry 1 Hassanein Waleed H · CIK 0001430466 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 464,008 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $55.00 to $55.10, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| August 24, 2022 Filed Aug 25, 2022 21:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 3,591 | $50.13 | $180,016.83 |
DisclosureSEC source: 0000899243-22-029754 · doc4.xml · nonDerivative · entry 2 Hassanein Waleed H · CIK 0001430466 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 466,285 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $50.00 to $50.24, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| August 23, 2022 Filed Aug 25, 2022 21:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 16,409 | $50.04 | $821,106.36 |
DisclosureSEC source: 0000899243-22-029754 · doc4.xml · nonDerivative · entry 1 Hassanein Waleed H · CIK 0001430466 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 469,876 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $50.00 to $50.24, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| August 12, 2022 Filed Aug 15, 2022 21:50 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 7,000 | $48.00 | $336,000.00 |
DisclosureSEC source: 0000899243-22-028660 · doc4.xml · nonDerivative · entry 2 Hassanein Waleed H · CIK 0001430466 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 486,285 F1 · kind: Represents a sale of shares of common stock to generate cash for the payment of taxes, including estimated taxes, due as a result of the vesting or settlement of certain equity-based awards or the exercise of stock options as permitted by the lock-up agreement, dated August 3, 2022, among the Reporting Person, J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC and Cowen and Company, LLC as the representatives of the underwriters named therein. Read SEC document |
| August 11, 2022 Filed Aug 15, 2022 21:50 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 12,929 | $46.74 | $604,301.46 |
DisclosureSEC source: 0000899243-22-028660 · doc4.xml · nonDerivative · entry 1 Hassanein Waleed H · CIK 0001430466 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 493,285 F1 · kind: Represents a sale of shares of common stock to generate cash for the payment of taxes, including estimated taxes, due as a result of the vesting or settlement of certain equity-based awards or the exercise of stock options as permitted by the lock-up agreement, dated August 3, 2022, among the Reporting Person, J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC and Cowen and Company, LLC as the representatives of the underwriters named therein. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $46.39 to $47.26, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| August 05, 2022 Filed Aug 9, 2022 22:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 20,000 | $45.13 | $902,600.00 |
DisclosureSEC source: 0000899243-22-028142 · doc4.xml · nonDerivative · entry 1 Hassanein Waleed H · CIK 0001430466 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 506,214 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $45.00 to $45.40, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 22:45 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | GrantStock Option (Right to Buy) · Derivative | 250,000 | $0.00 Strike: $13.28 | $0.00 |
DisclosureSEC source: 0000899243-22-007676 · doc4.xml · derivative · entry 1 Hassanein Waleed H · CIK 0001430466 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2032-02-22 F1 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 22, 2026. Read SEC document |
| January 06, 2022 Filed Jan 7, 2022 22:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 122,371 | $0.00 Strike: $0.28 | $0.00 |
DisclosureSEC source: 0000899243-22-001372 · doc4.xml · derivative · entry 2 Hassanein Waleed H · CIK 0001430466 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 122,371 shares Expires 2023-05-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the reporting person's cash exercise of a stock option. F2 · derivative.exercise_date: The option is fully vested. Read SEC document |
| January 06, 2022 Filed Jan 7, 2022 22:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 122,371 | $0.28 | $34,263.88 |
DisclosureSEC source: 0000899243-22-001372 · doc4.xml · nonDerivative · entry 1 Hassanein Waleed H · CIK 0001430466 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 526,214 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the reporting person's cash exercise of a stock option. Read SEC document |
| April 05, 2021 Filed Apr 7, 2021 22:35 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 125,000 | $0.00 Strike: $0.28 | $0.00 |
DisclosureSEC source: 0000899243-21-015325 · doc4.xml · derivative · entry 2 Hassanein Waleed H · CIK 0001430466 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,371 Underlying: Common Stock · 125,000 shares Expires 2023-05-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option is fully vested. Read SEC document |
| April 05, 2021 Filed Apr 7, 2021 22:35 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 125,000 | $0.28 | $35,000.00 |
DisclosureSEC source: 0000899243-21-015325 · doc4.xml · nonDerivative · entry 1 Hassanein Waleed H · CIK 0001430466 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 403,843 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 22:17 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 5,238 | $41.85 | $219,210.30 |
DisclosureSEC source: 0000899243-21-014907 · doc4.xml · nonDerivative · entry 3 Hassanein Waleed H · CIK 0001430466 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 278,843 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $41.54 to $42.26 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 22:17 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 23,727 | $41.07 | $974,467.89 |
DisclosureSEC source: 0000899243-21-014907 · doc4.xml · nonDerivative · entry 2 Hassanein Waleed H · CIK 0001430466 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 284,081 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $40.54 to $41.53 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 22:17 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 31,035 | $40.09 | $1,244,193.15 |
DisclosureSEC source: 0000899243-21-014907 · doc4.xml · nonDerivative · entry 1 Hassanein Waleed H · CIK 0001430466 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 307,808 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $39.54 to $40.53 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 02:17 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 35,007 | $0.00 Strike: $2.21 | $0.00 |
DisclosureSEC source: 0000899243-21-011241 · doc4.xml · derivative · entry 4 Hassanein Waleed H · CIK 0001430466 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 193,075 Underlying: Common Stock · 35,007 shares Expires 2027-06-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, June 22, 2017. Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 02:17 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 1,964 | $34.67 | $68,091.88 |
DisclosureSEC source: 0000899243-21-011241 · doc4.xml · nonDerivative · entry 3 Hassanein Waleed H · CIK 0001430466 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 338,843 F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $34.50 to $34.84 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 02:17 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 33,043 | $33.74 | $1,114,870.82 |
DisclosureSEC source: 0000899243-21-011241 · doc4.xml · nonDerivative · entry 2 Hassanein Waleed H · CIK 0001430466 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 340,807 F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $33.50 to $34.49 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 02:17 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 35,007 | $2.21 | $77,365.47 |
DisclosureSEC source: 0000899243-21-011241 · doc4.xml · nonDerivative · entry 1 Hassanein Waleed H · CIK 0001430466 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 373,850 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 22:52 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | GrantStock Option (Right to Buy) · Derivative | 310,000 | $0.00 Strike: $38.46 | $0.00 |
DisclosureSEC source: 0000899243-21-008457 · doc4.xml · derivative · entry 1 Hassanein Waleed H · CIK 0001430466 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 310,000 Underlying: Common Stock · 310,000 shares Expires 2031-02-24 F1 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021. Read SEC document |
| January 05, 2021 Filed Jan 14, 2021 23:56 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 123,414 | $0.00 Strike: $0.39 | $0.00 |
DisclosureSEC source: 0000899243-21-002088 · doc4.xml · derivative · entry 2 Hassanein Waleed H · CIK 0001430466 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 123,414 shares Expires 2021-09-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option is fully vested. Read SEC document |
| January 05, 2021 Filed Jan 14, 2021 23:56 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 123,414 | $0.39 | $48,131.46 |
DisclosureSEC source: 0000899243-21-002088 · doc4.xml · nonDerivative · entry 1 Hassanein Waleed H · CIK 0001430466 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 338,843 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 27, 2020 Filed Mar 30, 2020 20:57 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $0.39 | $0.00 |
DisclosureSEC source: 0000899243-20-009647 · doc4.xml · derivative · entry 2 Hassanein Waleed H · CIK 0001430466 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,414 Underlying: Common Stock · 100,000 shares Expires 2021-09-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option is fully vested. Read SEC document |
| March 27, 2020 Filed Mar 30, 2020 20:57 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 100,000 | $0.39 | $39,000.00 |
DisclosureSEC source: 0000899243-20-009647 · doc4.xml · nonDerivative · entry 1 Hassanein Waleed H · CIK 0001430466 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 215,429 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 27, 2020 Filed Mar 6, 2020 23:10 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | GrantStock Option (Right to Buy) · Derivative | 178,000 | $0.00 Strike: $16.14 | $0.00 |
DisclosureSEC source: 0000899243-20-007510 · doc4.xml · derivative · entry 1 Hassanein Waleed H · CIK 0001430466 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,000 Underlying: Common Stock · 178,000 shares Expires 2030-02-27 F1 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 27, 2020. Read SEC document |
| August 09, 2019 Filed Aug 13, 2019 22:58 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $0.28 | $0.00 |
DisclosureSEC source: 0000899243-19-021675 · doc4.xml · derivative · entry 2 Hassanein Waleed H · CIK 0001430466 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 247,371 Underlying: Common Stock · 6,000 shares Expires 2023-05-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option is fully vested. Read SEC document |
| August 09, 2019 Filed Aug 13, 2019 22:58 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 6,000 | $0.28 | $1,680.00 |
DisclosureSEC source: 0000899243-19-021675 · doc4.xml · nonDerivative · entry 1 Hassanein Waleed H · CIK 0001430466 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,429 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 13, 2019 Filed Jun 14, 2019 22:05 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 4,000 | $0.00 Strike: $0.28 | $0.00 |
DisclosureSEC source: 0000899243-19-017089 · doc4.xml · derivative · entry 2 Hassanein Waleed H · CIK 0001430466 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 253,371 Underlying: Common Stock · 4,000 shares Expires 2023-05-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option is fully vested. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.